Doctor profile · Federal record
Dr. JENNIFER LYNCH, FNP-C
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · HARTSVILLE, SC
- NPI 1740663038
- Accepts Medicare
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1268 S 4TH ST
HARTSVILLE, SC 295500703
(843) 332-3422 - Mailing address
-
PO BOX 1090
HARTSVILLE, SC 295511090
Credentials & registration
- NPI registered
- July 2015 — 11 yrs on file
- Profile last updated
- September 13, 2017
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- South Carolina #19595
- Medicaid
- SC #NP3321
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740663038. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
887
Distinct HCPCS
10
Medicare allowed
$21,404
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
82947 |
Blood glucose (sugar) level | 107 | 58 | $4 | |
96372 |
Injection of drug or substance under skin or into muscle | 102 | 46 | $11 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 99 | 32 | $50 | |
81003 |
Automated urinalysis test | 94 | 64 | $2 | |
83036 |
Hemoglobin a1c level | 85 | 50 | $9 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 81 | 32 | $101 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 54 | 11 | $22 | |
96375 |
Injection of additional new drug or substance into vein | 48 | 18 | $4 | |
85018 |
Blood count, hemoglobin | 47 | 17 | $2 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 44 | 20 | $16 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 70. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$2,104
Transactions
107
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 41 | $628.02 | |
| Lilly USA, LLC | 15 | $223.80 | |
| Abbott Laboratories | 9 | $144.34 | |
| Lundbeck LLC | 8 | $143.44 | |
| Alnylam Pharmaceuticals Inc. | 1 | $124.80 | |
| PFIZER INC. | 6 | $112.93 | |
| Novartis Pharmaceuticals Corporation | 5 | $96.21 | |
| AstraZeneca Pharmaceuticals LP | 5 | $87.12 | |
| Amgen Inc. | 4 | $68.16 | |
| Novo Nordisk Inc | 3 | $60.37 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $41.00 | |
| Ardelyx, Inc. | 2 | $36.57 | |
| Otsuka America Pharmaceutical, Inc. | 2 | $33.34 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31.89 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,974
Patients
915
Total drug cost
$617,485
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 381 | 96 | $11,271 |
| Atorvastatin Calcium | Generic | 325 | 119 | $7,494 |
| Amlodipine Besylate | Generic | 304 | 105 | $3,553 |
| Levothyroxine Sodium | Generic | 254 | 75 | $47,394 |
| Alprazolam | Generic | 237 | 35 | $1,610 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 173 | 50 | $4,673 |
| Mounjaro (Tirzepatide) | Brand | 168 | 44 | $200,442 |
| Tramadol Hcl | Generic | 155 | 31 | $1,721 |
| Trulicity (Dulaglutide) | Brand | 151 | 50 | $327,149 |
| Lisinopril | Generic | 142 | 51 | $1,910 |